World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
51
Citations
8717
World Ranking
4158
National Ranking
1897

Jianlin Gong publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Jianlin Gong sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 124 publications — 8th percentile

8% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Jianlin Gong D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Jianlin Gong sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 51 D-Index — 17th percentile

17% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Jianlin Gong is affiliated with Boston University in the United States and conducts research primarily in the field of Medicine. Their work focuses on several subfields including Surgery, Molecular Biology, Immunology, Infectious Diseases, and Radiology, Nuclear Medicine and Imaging.

The main topics covered in Jianlin Gong's research encompass a variety of areas within medical science. These include:

  • Esophageal Cancer Research and Treatment
  • Heat shock proteins research
  • Toxin Mechanisms and Immunotoxins
  • Viral gastroenteritis research and epidemiology
  • Radiomics and Machine Learning in Medical Imaging
  • Advanced X-ray and CT Imaging
  • Gastric Cancer Management and Outcomes

Jianlin Gong has authored and co-authored several publications spanning these topics. Notable papers include:

  • A Novel Heat Shock Protein 70-Based Vaccine Prepared from DC Tumor Fusion Cells: An Update, 2023, published in Methods in Molecular Biology
  • Using High-Repeatable Radiomic Features Improves the Cross-Institutional Generalization of Prognostic Model in Esophageal Cancer Receiving Definitive Chemoradiotherapy, 2024, published in International Journal of Radiation Oncology*Biology*Physics
  • Co-occurrence patterns of esophageal and stomach cancer across 204 countries and territories: a spatial correspondence and systematic analysis, 2025, published in Frontiers in Oncology
  • Correction: Co-occurrence patterns of esophageal and stomach cancer across 204 countries and territories: a spatial correspondence and systematic analysis, 2025, published in Frontiers in Oncology
  • UBL3 Governs VEGFR Inhibitor Resistance by Activating NOTCH Signaling in Renal Cell Carcinoma, 2025, published in Drug Resistance Updates

Frequent co-authors in Jianlin Gong's research include:

  • Jiayao Xu
  • Huiqiong Han
  • Zehua Wang
  • Guanyu Chen
  • Desheng Weng

Jianlin Gong publishes regularly in venues such as Frontiers in Oncology, Methods in Molecular Biology, International Journal of Radiation Oncology*Biology*Physics, and Drug Resistance Updates.

Best Publications

  • Fusion cell vaccination of patients with metastatic breast and renal cancer induces immunological and clinical responses.

    David Avigan;Baldev Vasir;Jianlin Gong;Virginia Borges

  • Interaction of Glycogen Synthase Kinase 3β with the DF3/MUC1 Carcinoma-Associated Antigen and β-Catenin

    Yongqing Li;Ajit Bharti;Dongshu Chen;Jianlin Gong

  • Fusions of human ovarian carcinoma cells with autologous or allogeneic dendritic cells induce antitumor immunity.

    Jianlin Gong;Najmosama Nikrui;Dongshu Chen;Shigeo Koido

  • Reversal of tolerance to human MUC1 antigen in MUC1 transgenic mice immunized with fusions of dendritic and carcinoma cells

    Jianlin Gong;Dongshu Chen;Masahiro Kashiwaba;Yongqing Li

  • Induction of Antitumor Immunity by Vaccination of Dendritic Cells Transfected with MUC1 RNA

    Shigeo Koido;Masahiro Kashiwaba;Dongshu Chen;Sandra Gendler

  • Activation of antitumor cytotoxic T lymphocytes by fusions of human dendritic cells and breast carcinoma cells

    Jianlin Gong;David Avigan;Dongshu Chen;Zekui Wu

  • Breast cancer–associated antigen, DF3/MUC1, induces apoptosis of activated human T cells

    Claude D. Gimmi;Briggs W. Morrison;Brigitte A. Mainprice;John G. Gribben

  • Extracellular HSPs: The Complicated Roles of Extracellular HSPs in Immunity.

    Stuart K. Calderwood;Jianlin Gong;Ayesha Murshid

  • The Role of Heat Shock Proteins in Antigen Cross Presentation

    Ayesha Murshid;Jianlin Gong;Stuart Keith Calderwood

  • Hsp70-Bag3 interactions regulate cancer-related signaling networks

    Teresa A. Colvin;Vladimir L. Gabai;Jianlin Gong;Stuart K. Calderwood

  • Message in a bottle: role of the 70-kDa heat shock protein family in anti-tumor immunity.

    Stuart K. Calderwood;Stuart K. Calderwood;Jimmy R. Theriault;Jianlin Gong

  • Immunization against murine multiple myeloma with fusions of dendritic and plasmacytoma cells is potentiated by interleukin 12.

    Jianlin Gong;Jianlin Gong;Shigeo Koido;Shigeo Koido;Dongshu Chen;Dongshu Chen;Yasuhiro Tanaka;Yasuhiro Tanaka

  • Treatment with Chemotherapy and Dendritic Cells Pulsed with Multiple Wilms' Tumor 1 (WT1)–Specific MHC Class I/II–Restricted Epitopes for Pancreatic Cancer

    Shigeo Koido;Sadamu Homma;Masato Okamoto;Kazuki Takakura

  • Induction of antigen-specific antitumor immunity with adenovirus-transduced dendritic cells.

    J Gong;L Chen;D Chen;M Kashiwaba

  • A Heat Shock Protein 70-Based Vaccine with Enhanced Immunogenicity for Clinical Use

    Jianlin Gong;Yunfei Zhang;John Durfee;Desheng Weng

  • Induction of heat shock proteins by heregulin β1 leads to protection from apoptosis and anchorage-independent growth

    Abdul Khaleque;Ajit Bharti;Douglas Sawyer;Jianlin Gong

  • Enhanced Immunogenicity of Heat Shock Protein 70 Peptide Complexes from Dendritic Cell-Tumor Fusion Cells

    Yutaka Enomoto;Ajit Bharti;Ad Abdul Khaleque;Baizheng Song

  • How is the immune response affected by hyperthermia and heat shock proteins

    Stuart K Calderwood;Jimmy R Theriault;Jianlin Gong

  • Heat Shock Protein 90 Mediates Efficient Antigen Cross Presentation through the Scavenger Receptor Expressed by Endothelial Cells-I

    Ayesha Murshid;Jianlin Gong;Stuart K. Calderwood;Stuart K. Calderwood

  • Prevention of Spontaneous Breast Carcinoma by Prophylactic Vaccination with Dendritic/Tumor Fusion Cells

    Jianchuan Xia;Yasuhiro Tanaka;Shigeo Koido;Chunlei Liu;Chunlei Liu

  • HSF1 regulation of β-catenin in mammary cancer cells through control of HuR/elavL1 expression

    Shiuh-Dih Chou;Ayesha Murshid;Takanori Eguchi;Jianlin Gong

Frequent Co-Authors

Stuart K. Calderwood
Stuart K. Calderwood Beth Israel Deaconess Medical Center
Donald Kufe
Donald Kufe Harvard University
Vasso Apostolopoulos
Vasso Apostolopoulos RMIT University
Kenneth C. Anderson
Kenneth C. Anderson Harvard University
Steven P. Treon
Steven P. Treon Harvard University
Haruo Sugiyama
Haruo Sugiyama Osaka University
Dharminder Chauhan
Dharminder Chauhan Harvard University
Noopur Raje
Noopur Raje Harvard University
Paul G. Richardson
Paul G. Richardson Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, exploring related online degrees can open diverse career opportunities in healthcare and research. Many students begin with foundational programs, such as online nursing programs for non nurses, which provide a strong clinical background even for those new to the field.

Accelerated routes are also popular among professionals seeking quicker entry into nurse practitioner roles. Programs like the accelerated FNP program offer a streamlined curriculum, helping students meet the growing demand for family nurse practitioners.

For licensed family nurse practitioners looking to specialize further, transitioning via an FNP to acute care NP bridge program can expand clinical expertise and open doors in critical care settings, a field closely aligned with immunology research and patient care.

Financially, it’s valuable to review earning potential. Resources like how much do dnps make provide insight into salary expectations across states, helping graduates plan their careers with realistic financial goals in mind.

Best Scientists Citing Jianlin Gong

Trending Scientists

Recently Published Articles